Per Pfeiffer
Impact in
- Oncology top 0.5%
- Colorectal Cancer Treatments and Studies
- Cancer Treatment and Pharmacology
- Pancreatic and Hepatic Oncology Research
- Hepatology top 1%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
- Oncology 237
- Colorectal Cancer Treatments and Studies 121
- Cancer Treatment and Pharmacology 59
- Pancreatic and Hepatic Oncology Research 52
-
- Gastric Cancer Management and Outcomes 63
- Co-authors
- Camilla Qvortrup (68 shared papers)Bengt Glimelius (56 shared papers)Michael Bau Mortensen (45 shared papers)Halfdan Sørbye (46 shared papers)Benny Vittrup Jensen (44 shared papers)Carsten Rose (10 shared papers)Jon Kroll Bjerregaard (31 shared papers)Sönke Detlefsen (34 shared papers)
In The Last Decade
Per Pfeiffer
287 papers receiving 6.2k citations
Per Pfeiffer's Hit Papers
Peers
Comparison fields: 5 of 126
- Oncology 3.9k
- Hepatology 639
- Cancer Research 1.2k
- Pulmonary and Respiratory Medicine 1.8k
- Pathology and Forensic Medicine 800
Countries citing papers authored by Per Pfeiffer
This map shows the geographic impact of Per Pfeiffer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Per Pfeiffer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Per Pfeiffer more than expected).
Fields of papers citing papers by Per Pfeiffer
This network shows the impact of papers produced by Per Pfeiffer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Per Pfeiffer. The network helps show where Per Pfeiffer may publish in the future.
Co-authors
The 25 scholars most cited alongside Per Pfeiffer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 302 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Efficacy and Safety of Pembrolizumab for Heavily Pretreated Patients With Advanced, Metastatic Adenocarcinoma or Squamous Cell Carcinoma of the Esophagus Hit paper breakdown → | 2018 | 362 |
| 2 | Pancreatic cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up Hit paper breakdown → | 2023 | 190 |
| 3 | 2020 | 150 | |
| 4 | 1993 | 141 | |
| 5 | 1996 | 135 | |
| 6 | 1996 | 127 | |
| 7 | 2014 | 123 | |
| 8 | 1995 | 95 | |
| 9 | 2009 | 93 | |
| 10 | 2015 | 81 | |
| 11 | 2013 | 79 | |
| 12 | 2008 | 78 | |
| 13 | 1998 | 77 | |
| 14 | 2013 | 76 | |
| 15 | 2014 | 72 | |
| 16 | 2016 | 70 | |
| 17 | 2014 | 68 | |
| 18 | 2006 | 68 | |
| 19 | 1990 | 66 | |
| 20 | 2017 | 63 |
About Per Pfeiffer
Per Pfeiffer is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Surgery, Cancer Research and Hepatology, having authored 302 papers that have together received 6.3k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (121 papers), Gastric Cancer Management and Outcomes (63 papers), Cancer Treatment and Pharmacology (59 papers), Pancreatic and Hepatic Oncology Research (52 papers), Hepatocellular Carcinoma Treatment and Prognosis (48 papers), Cancer Genomics and Diagnostics (37 papers), Genetic factors in colorectal cancer (36 papers) and Intraperitoneal and Appendiceal Malignancies (25 papers). The work is most often cited by research in Oncology (3.9k citations), Hepatology (639 citations), Cancer Research (1.2k citations), Pulmonary and Respiratory Medicine (1.8k citations) and Pathology and Forensic Medicine (800 citations). Per Pfeiffer has collaborated with scholars based in Denmark, Sweden and Norway. Frequent co-authors include Camilla Qvortrup, Bengt Glimelius, Michael Bau Mortensen, Halfdan Sørbye, Benny Vittrup Jensen, Carsten Rose, Jon Kroll Bjerregaard, Sönke Detlefsen, Martin Graversen and Mette Yilmaz. Their work appears in journals such as Acta Oncologica, Annals of Oncology, Journal of Clinical Oncology, European Journal of Cancer and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.